[1] |
NADERI N,YANG D T.Lymphoplasmacytic lymphoma and Waldenström macroglobulinemia[J]. Arch Pathol Lab Med,2013,137(4):580-585.
|
[2] |
中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会白血病淋巴瘤学组,中国抗淋巴瘤联盟. 淋巴浆细胞淋巴瘤/华氏巨球蛋白血症诊断与治疗中国专家共识(2016年版)[J]. 中华血液学杂志, 2016, 37(9):729-734.
|
[3] |
VARETTONI M, ARCAINI L, ZIBELLINI S, et al.Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms[J]. Blood, 2013, 121(13):2522-2528.
|
[4] |
TREON S P, XU L, YANG G, et al.MYD88 L265P somatic mutation in Waldenström's macroglobulinemia[J]. N Engl J Med, 2012, 367(9):826-833.
|
[5] |
TREON S P, HUNTER Z R, CASTILLO J J, et al.Waldenström macrogloblinemia[J]. Hematol Oncol Clin North Am,2014,28(5):945-970.
|
[6] |
陈海敏, 侯健. MyD88 L265P突变与B细胞肿瘤[J]. 中国实验血液学杂志, 2014, 22(1):241-244.
|
[7] |
SCHMIDT J, FEDERMANN B, SCHINDLER N, et al.MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity[J]. Br J Haematol,2015,169(6):795-803.
|
[8] |
XU L, HUNTER Z R, YANG G, et al.Detection of MYD88 L265P in peripheral blood of patients with Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance[J]. Leukemia, 2014, 28(8):1698-1704.
|
[9] |
余思思, 黄建鸣, 张智慧. 弥漫大B细胞淋巴瘤MYD88 L265P突变研究进展[J]. 肿瘤预防与治疗, 2016, 29(2):119-122.
|